^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

isatuximab subcutaneous (SAR650984 SC)

i
Other names: SAR650984 SC, Sarclisa subcutaneous
Associations
Trials
Company:
Sanofi
Drug class:
CD38 inhibitor, Apoptosis inducer
Associations
Trials